End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,780 KRW | +1.17% | +4.47% | -16.69% |
Business Summary
Number of employees: 463
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 154,039 | 100.0 % | 151,071 | 100.0 % | -1.93% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.0
%
| 151,665 | 98.5 % | 149,518 | 99.0 % | -1.42% |
Japan
0.6
%
| 1,786 | 1.2 % | 831 | 0.6 % | -53.46% |
Vietnam
0.3
%
| 323 | 0.2 % | 447 | 0.3 % | +38.17% |
Peru
0.1
%
| - | - | 89 | 0.1 % | - |
Indonesia
0.0
%
| 197 | 0.1 % | 63 | 0.0 % | -68.02% |
Mongolia
0.0
%
| 32 | 0.0 % | 61 | 0.0 % | +92.36% |
Thailand
0.0
%
| - | - | 33 | 0.0 % | - |
Hong Kong
0.0
%
| 18 | 0.0 % | 17 | 0.0 % | -2.63% |
Malaysia
0.0
%
| - | - | 12 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Soon-Ok Jeong
CEO | Chief Executive Officer | 73 | - |
Yong-Hwan Yoo
CEO | Chief Executive Officer | 50 | - |
Ju-Won Cho
SAM | Sales & Marketing | 54 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yong-Hwan Yoo
CEO | Chief Executive Officer | 50 | - |
Joong-Hyeop Kim
BRD | Director/Board Member | 80 | - |
Soon-Ok Jeong
CEO | Chief Executive Officer | 73 | - |
Seok-Ho Lee
BRD | Director/Board Member | 77 | - |
Sung-Jun Yoon
BRD | Director/Board Member | 50 | - |
Young-Jun Cho
BRD | Director/Board Member | 53 | - |
Taek-Ki Hong
BRD | Director/Board Member | 69 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,586,811 | 7,939,628 ( 42.72 %) | 245,820 ( 1.323 %) | 42.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
245,820 | 1.32% | 2,784,590 $ | |
47,000 | 0.14% | 253,809 $ |
Company contact information
REYON PHARMACEUTICAL Co., Ltd.
8th Floor, Cosmo Tower 416 Yeongdong-daero
06176, Seoul
+
http://reyonpharm.co.krSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-16.69% | 184M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A102460 Stock
- Company REYON Pharmaceutical Co., Ltd.